首页> 美国卫生研究院文献>Archives of Disease in Childhood >Growth and growth hormone secretion after bone marrow transplantation.
【2h】

Growth and growth hormone secretion after bone marrow transplantation.

机译:骨髓移植后的生长和生长激素分泌。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study analyses the growth and the growth hormone secretion of children given various conditioning protocols before bone marrow transplantation (BMT). Twenty nine children (14 boys, 15 girls) given BMT were classified according to their conditioning protocol: total body irradiation (TBI) given as a single exposure of 10 Grays (Gy, group I, 11 cases), or 8 Gy (group II, four cases), 12 Gy given as six fractionated doses (Group III, seven cases), or chemotherapy alone (group IV, seven cases). The arginine-insulin stimulated growth hormone peak, 2-7.5 years after BMT, was > 10 micrograms/l in all patients except four from group I (6.9-8.9 micrograms/l). A second growth hormone secretion evaluation was performed in 10 group I patients because of persistent low growth velocity despite a normal growth hormone peak. There were no significant changes in the mean (SEM) stimulated growth hormone peak (18.4 (2.2) v 20.1 (3.6) micrograms/l) at 3 (0.3) to 5.2 (0.6) years after BMT. The sleep growth hormone peaks and concentrations (n = 6) were normal. The mean cumulative height changes (SD) during the three years after BMT were: -1.4 (0.2) in group I, -0.1 (0.4) in group II, -0.4 (0.2) in group III, and 1.5 (0.5) in group IV; this was significant in groups I and IV. The final heights of two monozygotic twins (BMT donor and recipient) had differed by 17.5 cm, despite them both having normal growth hormone peaks and puberty. Eight patients, treated for congenital immune deficiency syndrome, were growth retarded at the time of BMT. Of these, only those conditioned by chemotherapy alone had significant catch up growth (2(0.6)SD) while those conditioned by a single Gy exposure did not (0(0.4)SD). It is concluded that the total radiation dose is critical for growth evolution, as is the fractionation schedule. For the TBI doses and the interval since BMT studied, there was no correlation between growth hormone peak and the height loss. The rapidity of decreased growth velocity after TBI and the comparison between the monozygotic twins suggest that radiation induced skeletal lesions are partly responsible for the decreased growth.
机译:这项研究分析了在骨髓移植(BMT)前采用各种调节方案的儿童的生长情况和生长激素分泌。接受BMT治疗的29名儿童(14名男孩,15名女孩)根据他们的调节方案进行了分类:全身照射(TBI)为单次暴露10灰(Gy,I组,11例)或8 Gy(II组) ,4例),以6次分次剂量(12组)给予12 Gy(III组,7例)或单独进行化疗(IV组,7例)。除第一组中的四名患者外(6.9-8.9微克/升),BMT后2-7.5年,所有患者中精氨酸-胰岛素刺激的生长激素峰值均> 10微克/升。尽管生长激素峰值正常,但由于持续的低生长速度,对10名I组患者进行了第二次生长激素分泌评估。 BMT后3(0.3)至5.2(0.6)年,平均(SEM)刺激的生长激素峰值(18.4(2.2)v 20.1(3.6)微克/升)没有明显变化。睡眠生长激素峰值和浓度(n = 6)正常。 BMT后三年中的平均累积身高变化(SD)为:第一组-1.4(0.2),第二组-0.1(0.4),第三组-0.4(0.2),第三组1.5(0.5) IV;在第一和第四组中,这一点很重要。尽管它们均具有正常的生长激素峰和青春期,但两个单卵双胞胎(BMT供体和受体)的最终身高相差17.5厘米。 BMT时,有8例因先天性免疫缺陷综合征接受治疗的患者生长迟缓。在这些中,仅那些单独通过化学疗法处理的动物具有显着的追赶生长(2(0.6)SD),而那些仅通过一次Gy暴露处理的动物却没有明显的追赶生长(0(0.4)SD)。结论是总辐射剂量和分馏时间表对生长发育至关重要。对于TBI剂量和自BMT研究以来的时间间隔,生长激素峰值与身高损失之间没有相关性。 TBI后生长速度下降的速度很快,以及单卵双胞胎之间的比较表明,辐射诱导的骨骼病变是造成生长下降的部分原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号